Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The company returns high margins, thereby supporting business profitability.

● The company is in a robust financial situation considering its net cash and margin position.

● Its low valuation, with P/E ratio at 5.84 and 8.24 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.